Physician profile
John E Valle
NPI 1073520391
$3,580.83
in general payments reported to CMS, 2019-2025
14 companies · $273 in 2025
The $273 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,011 · 2020: $335 · 2021: $29.01 · 2022: $731 · 2023: $501 · 2024: $702 · 2025: $273.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,223 · Entertainment: $252.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,223.16 |
| Entertainment | $252.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $1,498.33 | 2019-2025 | Myday Contact Lens, Clariti Contact Lens, Misight Contact Lens |
| Alcon Vision LLC | $834.27 | 2020-2025 | Total30, Precision7 |
| Optos, INC. | $252.18 | 2023-2024 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Bausch & Lomb Americas INC. | $187.21 | 2022-2024 | Biotrue One Day, Infuse |
| Abbvie INC. | $121.46 | 2023 | Durysta |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $119.71 | 2019 | |
| Abb Con-Cise Optical Group LLC | $107.17 | 2019-2020 | |
| Dompe US, INC. | $101.50 | 2023 | Oxervate |
| Sun Pharmaceutical Industries INC. | $92.84 | 2020-2024 | |
| Allergan, INC. | $92.83 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $79.40 | 2019-2024 | |
| Novartis Pharmaceuticals Corporation | $46.57 | 2019-2023 | |
| Eyevance Pharmaceuticals LLC | $27.96 | 2019-2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Valle listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.